weight watchers semaglutide WeightWatchers and Ozempic: The company is pivoting its marketing away from “wellness.” Weight Watchers discontinued compound semaglutide.

So they were having better outcomes, uh, with the intended, with the intent to lose weight

Retatrutide adds glucagon receptor agonism on top of both, which is why the obesity field treats it as a step change rather than an incremental dose tweak

In addition, 37.0% of people treated with 2.4 mg semaglutide achieved improvements in liver fibrosis with no worsening of steatohepatitis compared to 22.5% on placebo

MeAgain uses a weight log and trend view so the pattern is easier to read than a pile of isolated numbers

It found that those who used GLP-1 medications had a lower risk of all-cause mortality (death from any cause) during the study period and also had lower risks of heart failure, stroke, and kidney injury

Previous analyses placed sygl-1 and lst-1 downstream of, or parallel to, GLP-1/Notch signaling and upstream of GLD differentiation regulators, but their relationship with FBF was unresolved [18, 25] (Fig 1B)